GR1000419B - Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. - Google Patents

Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.

Info

Publication number
GR1000419B
GR1000419B GR900100015A GR900100015A GR1000419B GR 1000419 B GR1000419 B GR 1000419B GR 900100015 A GR900100015 A GR 900100015A GR 900100015 A GR900100015 A GR 900100015A GR 1000419 B GR1000419 B GR 1000419B
Authority
GR
Greece
Prior art keywords
dosage form
acalcium
antagonist
supply
nicardipine
Prior art date
Application number
GR900100015A
Other languages
English (en)
Other versions
GR900100015A (en
Inventor
Rosa Stephen C De
Joseph C Deters
David R Swanson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GR900100015A publication Critical patent/GR900100015A/el
Publication of GR1000419B publication Critical patent/GR1000419B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Αποκαλύπτεται μια μορφή δοσολογίας (10) περιλαμβάνουσα ένα μέλος που επιλέγεται από την ομάδα που αποτελείται από nicardipine και τα φαρμακευτικώς αποδεκτά άλατά της για χορήγηση σε έναν ασθενή που χριεάζεται καρδιοαγγειακή θεραπεία. ω
GR900100015A 1989-01-30 1990-01-10 Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου. GR1000419B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30

Publications (2)

Publication Number Publication Date
GR900100015A GR900100015A (en) 1991-06-07
GR1000419B true GR1000419B (el) 1992-06-30

Family

ID=23173326

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100015A GR1000419B (el) 1989-01-30 1990-01-10 Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.

Country Status (11)

Country Link
EP (1) EP0455648B1 (el)
JP (1) JPH04503058A (el)
AU (1) AU621182B2 (el)
CA (1) CA2007106A1 (el)
DK (1) DK23790A (el)
ES (2) ES2054333T3 (el)
FI (1) FI913608A0 (el)
GR (1) GR1000419B (el)
IE (1) IE61872B1 (el)
PT (1) PT92994B (el)
WO (1) WO1990008536A1 (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
PT1035834E (pt) * 1997-12-05 2002-09-30 Alza Corp Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
CA2327685C (en) 1998-04-03 2008-11-18 Bm Research A/S Controlled release composition
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
DE602004031096D1 (de) 2003-03-26 2011-03-03 Egalet As Morphin-system mit kontrollierter freisetzung
WO2004084869A1 (en) 2003-03-26 2004-10-07 Egalet A/S Matrix compositions for controlled delivery of drug substances
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
ATE413864T1 (de) * 2005-01-27 2008-11-15 Alza Corp Orale osmotische darreichungsform mit membran mit hoher flussdichte
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
AU2010211220B2 (en) 2009-02-06 2013-08-01 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
WO2010149169A2 (en) 2009-06-24 2010-12-29 Egalet A/S Controlled release formulations
MX2014015880A (es) 2012-07-06 2015-08-05 Egalet Ltd Composiciones farmaceuticas disuasivas de abuso para liberacion controlada.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form

Also Published As

Publication number Publication date
AU4811490A (en) 1990-08-24
IE900296L (en) 1990-07-30
AU621182B2 (en) 1992-03-05
WO1990008536A1 (en) 1990-08-09
EP0455648A1 (en) 1991-11-13
DK23790A (da) 1990-07-31
CA2007106A1 (en) 1990-07-30
DK23790D0 (da) 1990-01-29
GR900100015A (en) 1991-06-07
IE61872B1 (en) 1994-11-30
ES2054333T3 (es) 1994-08-01
ES2026304A6 (es) 1992-04-16
PT92994B (pt) 1995-12-29
FI913608A0 (fi) 1991-07-29
PT92994A (pt) 1990-07-31
JPH04503058A (ja) 1992-06-04
EP0455648B1 (en) 1993-03-10

Similar Documents

Publication Publication Date Title
NO306377B1 (no) Doseform for avgivelse av et medikament
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
EP0552256A4 (el)
GR1000465B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.
MX9700081A (es) Composiciones farmaceuticas de tacrina.
FI925342A (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
IT9022471A0 (it) Procedimento e apparecchiatura per l'abbinamento univoco di farmaci corrispondenti a una terapia pescritta a un determinato paziente
NZ336055A (en) An oral sustained release formulation of opioids
WO1994027589A3 (en) Antidepressant dosage form
DK0459666T3 (da) Lægemidler mod impotens
HU883863D0 (en) Process for the preparation of producing and/or portionly form of therapeutical agents
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
IT1235153B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico della cataratta e composizioni farmaceutiche utili in tale trattamento
UA19756A1 (uk) Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей
ATE82120T1 (de) Kalziumzusaetze.
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
ATE59550T1 (de) Chlorpheniramine therapie.
NO912497L (no) Doseringsform for administrering av kalsiumantagonist.
GB8808995D0 (en) Apparatus for oral administration of medicament
TH19526A (th) วิธีการและสารผสมสำหรับรักษาโรคตับอักเสบชนิดออโตอิมมูน
IT8903497A0 (it) Somministrazione di miscele gassoseper uso terapeutico o medicinale ingenere
IT8748222A0 (it) Tropina da solo o in combinazione uso di un medicamento a base di un con l'ormone follicolo-stimolante fattore di rilascio della somatonel trattamento della sterilita